Search

Your search keyword '"Khatchadourian, Karine"' showing total 6 results
Start Over Author "Khatchadourian, Karine" Publication Year Range Last 3 years
6 results on '"Khatchadourian, Karine"'

1. Teaching Adolescents With Type 1 Diabetes Self-Compassion (TADS) to Reduce Diabetes Distress: Protocol for a Randomized Controlled Trial

Author

Dover, Saunya, primary, Ahmet, Alexandra, additional, Bluth, Karen, additional, Feldman, Brian M, additional, Goldbloom, Ellen B, additional, Goldfield, Gary S, additional, Hamilton, Sarah, additional, Imran, Omar, additional, Khalif, Adam, additional, Khatchadourian, Karine, additional, Lawrence, Sarah, additional, Leonard, Andrew, additional, Liu, Kuan, additional, Ouyang, Yongdong, additional, Peeters, Corien, additional, Shah, Jai, additional, Spector, Noah, additional, Zuijdwijk, Caroline, additional, and Robinson, Marie-Eve, additional

Published
2023
Full Text
View/download PDF

2. Canakinumab in addition to phosphate-binding and phosphaturia-inducing therapy were effective in achieving remission in a child with a large familial calcinotic tumour

Author

Ochoa, Maria, primary, Jurencak, Roman, additional, Smit, Kevin, additional, Carsen, Sasha, additional, Sawyer, Sarah L., additional, Robinson, Marie-Eve, additional, Khatchadourian, Karine, additional, Cheng, Hooi Peng, additional, Pagé, Marika, additional, Werier, Joel, additional, and Ward, Leanne Marie, additional

Published
2023
Full Text
View/download PDF

3. Cohort profile update: The Canadian Maternal–Infant Research on Environmental Chemicals Child Development study (MIREC‐CD PLUS)

Author

Fisher, Mandy, primary, Muckle, Gina, additional, Lanphear, Bruce, additional, Arbuckle, Tye E., additional, Braun, Joseph M., additional, Zidek, Angelika, additional, Vélez, Maria P., additional, Lupien, Nicole, additional, Bastien, Stephanie, additional, Ashley‐Martin, Jillian, additional, Oulhote, Youssef, additional, Borghese, Michael M., additional, Walker, Mark, additional, Asztalos, Elizabeth, additional, Bouchard, Maryse F., additional, Booij, Linda, additional, Palmert, Mark R., additional, Morrison, Katherine M., additional, Cummings, Elizabeth A., additional, Khatchadourian, Karine, additional, Panagiotopoulos, Constadina, additional, Glendon, Gord, additional, Shutt, Robin, additional, Abdul‐Fatah, Ammanie, additional, Seal, Kelsey, additional, and Fraser, William D., additional

Published
2023
Full Text
View/download PDF

4. Teaching Adolescents with type 1 Diabetes Self-compassion (TADS) to reduce diabetes distress: study protocol of a randomized controlled trial (Preprint)

Author

Dover, Saunya, primary, Ahmet, Alexandra, additional, Bluth, Karen, additional, Feldman, Brian M, additional, Goldbloom, Ellen B, additional, Goldfield, Gary S, additional, Hamilton, Sarah, additional, Imran, Omar, additional, Khalif, Adam, additional, Khatchadourian, Karine, additional, Lawrence, Sarah, additional, Leonard, Andrew, additional, Liu, Kuan, additional, Ouyang, Yondgong, additional, Peeters, Corien, additional, Shah, Jai, additional, Spector, Noah, additional, Zuijdwijk, Caroline, additional, and Robinson, Marie-Eve, additional

Published
2023
Full Text
View/download PDF

5. Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting

Author

Zuijdwijk, Caroline, Courtney, Jennilea, Mitsakakis, Nicholas, Hayawi, Lamia, Sutherland, Stephanie, Newhook, Dennis, Ahmet, Alexandra, Goldbloom, Ellen B., Khatchadourian, Karine, and Lawrence, Sarah

Subjects
Article Subject
Abstract

Objective. To determine the impact of the t:slim X2 insulin pump with Control-IQ technology on the quality of life and glycemic control in youth with type 1 diabetes (T1D) and their parents in a real-world setting. Research Design and Methods. We conducted a single-center, prospective study on pediatric patients (6–18 years old) with T1D using a Tandem t:slim X2 pump and initiating Control-IQ technology as part of routine care. Youth (≥8 years) and parents completed validated patient-reported outcome measures (PROMs) at baseline and the end of the study (16 weeks). Glycemic control measures were recorded at baseline and every 4 weeks until the end of the study. Results. Fifty-nine youth participated; the median (IQR) age was 13.8 (11.1, 15.7) years, and T1D duration was 6.3 (3.1, 8.4) years. INSPIRE scores (evaluating expectations (baseline) and impact (post) of Control-IQ technology) were favorable, unchanged at the end of the study for youth, and lower for parents (p=0.04). Other PROM scores improved by the end of the study with mean (95% CI) differences for youth and parents, respectively, as follows: Diabetes Impact and Device Satisfaction (DIDS) Scale Diabetes Impact −1.08 (−1.51, −0.64) (p

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results